Staining with lissamine green: a guide to dry eye

Article

Degree and pattern of staining with lissamine green is a good objective indicator of the severity of tear deficiency, according to a report published in the July issue of Eye and Contact Lens.

Degree and pattern of staining with lissamine green is a good objective indicator of the severity of tear deficiency, according to a report published in the July issue of Eye and Contact Lens.

James McCulley and colleagues from the University of Texas Southwestern Medical Center, USA found that the severity of dry eye correlates with the location of stain patterns. They examined the stain patterns in 22 patients with varying degrees of dry eye and in 11 patients with ocular disease who served as controls.

The researchers found that stains limited to the whites of the eyes between the lids toward the nose do not necessarily indicate dry eye but could be caused by environmental factors such as pollution. Stains that appear in the whites of the eye towards the ear are often symptomatic of dry eye. Finally, stains that appear on the cornea indicate a break in surface cells which can lead to serious bacterial infections.

The team suggested that these guidelines may allow for earlier diagnosis, allowing clinicians to offer more treatment options and preventing disease progression.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.